title: Inhibition of cholesterol absorption and synthesis in rats by sesamin.
abstract: The effects of sesamin, a lignan from sesame oil, on various aspects of cholesterol metabolism were examined in rats maintained on various dietary regimens. When given at a dietary level of 0.5% for 4 weeks, sesamin reduced the concentration of serum and liver cholesterol significantly irrespective of the presence or absence of cholesterol in the diet, except for one experiment in which the purified diet free of cholesterol was given. On feeding sesamin, there was a decrease in lymphatic absorption of cholesterol accompanying an increase in fecal excretion of neutral, but not acidic, steroids, particularly when the cholesterol-enriched diet was given. Sesamin inhibited micellar solubility of cholesterol, but not bile acids, whereas it neither bound taurocholate nor affected the absorption of fatty acids. Only a marginal proportion (ca. 0.15%) of sesamin administered intragastrically was recovered in the lymph. There was a significant reduction in the activity of liver microsomal 3-hydroxy-3-methylglutaryl coenzyme A reductase after feeding sesamin, although the activity of hepatic cholesterol 7 alpha-hydroxylase, drug metabolizing enzymes, and alcohol dehydrogenase remained uninfluenced. Although the weight and phospholipid concentration of the liver increased unequivocally on feeding sesamin, the histological examination by microscopy showed no abnormality, and the activity of serum GOT and GPT remained unchanged. Since sesamin lowered both serum and liver cholesterol levels by inhibiting absorption and synthesis of cholesterol simultaneously, it deserves further study as a possible hypocholesterolemic agent of natural origin.
authors.affiliation: Laboratory of Nutrition Chemistry, Kyushu University School of Agriculture, Fukuoka, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Hirose
authors.forename: T
authors.initials: T
authors.lastname: Inoue
authors.forename: K
authors.initials: K
authors.lastname: Nishihara
authors.forename: M
authors.initials: M
authors.lastname: Sugano
authors.forename: K
authors.initials: K
authors.lastname: Akimoto
authors.forename: S
authors.initials: S
authors.lastname: Shimizu
authors.forename: H
authors.initials: H
authors.lastname: Yamada
mesh_terms: D000042:Absorption; D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001219:Aspartate Aminotransferases / Q000097:blood; D002784:Cholesterol / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism*; D004149:Dioxoles / Q000097:blood / Q000737:chemistry / Q000494:pharmacology*; D005243:Feces / Q000737:chemistry; D017705:Lignans; D008196:Lymph / Q000737:chemistry; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D012715:Sesame Oil / Q000494:pharmacology*; D013656:Taurocholic Acid / Q000378:metabolism
chemical_list: D000924:Anticholesteremic Agents; D004149:Dioxoles; D017705:Lignans; D013656:Taurocholic Acid; D012715:Sesame Oil; D002784:Cholesterol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; C054125:sesamin